Open AccessClinical Performance of the BD CTGCTV2 Assay for the BD MAX System for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections
Author(s) -
Barbara Van Der Pol,
Edith Torres-Chavolla,
Salma Kodsi,
Charles K. Cooper,
Thomas E. Davis,
Kenneth H. Fife,
Stephanie N. Taylor,
Michael Augenbraun,
Charlotte A. Gaydos
Publication year - 2020
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001280
Subject(s) - neisseria gonorrhoeae , trichomonas vaginalis , chlamydia trachomatis , medicine , trichomonas , chlamydia , multiplex , urine , gynecology , gonorrhea , trichomonas vaginitis , sexually transmitted disease , trichomoniasis , immunoassay , obstetrics , virology , syphilis , microbiology and biotechnology , immunology , biology , antibody , bioinformatics , human immunodeficiency virus (hiv)
Diagnostic options to combat the increasing rates of sexually transmitted infections recorded throughout the world increasingly include multiplex assays. Here we describe the estimated sensitivity and specificity of a triplex molecular assay that simultaneously detects Chlamydia trachomatis (CT), Neisseria gonorrhoeae (or gonococci [GC]), and Trichomonas vaginalis (TV).